Navigation Links
Surefire Medical's Infusion System For Embolization Procedures Receives CE Mark Approval
Date:9/4/2012

WESTMINSTER, Colo., Sept. 5, 2012 /PRNewswire/ -- European regulators have approved Surefire Medical's Surefire Infusion System, a next generation device for chemo- and radioembolization procedures. The Colorado-based medical device company today announced that it is launching this product in the European market immediately.

"Surefire Medical developed this ground-breaking technology to provide interventional radiologists with improved embolization certainty during their infusion procedures," said Jim Chomas, CEO of Surefire Medical. "With the CE Mark approval, we are able to introduce the Surefire Infusion System, which may offer substantial advantages over a standard microcatheter, throughout Europe."

Clinical results
In a recent retrospective study of 29 patients, infusion of therapeutic agent with the Surefire Infusion System showed no angiographic evidence of reflux and no clinical evidence of non-target embolization. CT imaging in chemoembolization patients suggested a pattern of increased microsphere tumor penetration and contrast retention. 1

Additionally, the Surefire High-Flow Microcatheter System recently received U.S. FDA 510(k) clearance.  The Surefire Infusion System received FDA 510(k) clearance in June 2011.

As part of the international launch, Surefire Medical will participate in the upcoming annual meeting of the Cardiovascular and Interventional Radiological Society of Europe 2012 in Lisbon, Portugal.

1 J. D. Louie, E. A. Wang, S. Broadwell, B. C. Wible, A. Arepally, C. Nutting, L. Bester, D. Y. Sze. First in Man Experience with the Surefire Infusion System – A dedicated microcatheter system to eliminate reflux during embolotherapy. Presented during Society of Interventional Radiology Annual Scientific Meeting, March 2012.

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to increase embolization efficiency, minimize reflux and reduce damage to healthy tissue.  For more information, please visit www.surefiremedical.com.


'/>"/>
SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Surefire Medical Receives FDA Clearance For High-Flow Microcatheter
2. Riordan Lewis & Haden
3. Equity Partners Acquires Nutritional Therapy Provider DCRX Infusion
4. Global Infusion Pumps Market 2011-2015
5. CareFusion Expands Infusion Pump Interoperability
6. Aperture Health, Inc. focuses in on IV Therapy Value Creation and the Merger and Acquisition Activities in the Home Infusion Therapy Sector.
7. Saint Vincent Health System Selects onFocus Healthcare for Enterprise Performance Management
8. Institut Curie Acquires Four Advanced Radiotherapy Treatment Systems Including Three Varian TrueBeam Devices
9. TeleTracking Announces Real-Time Locating System (RTLS) Contract with Geisinger Health
10. Global Needle-Free Drug Injection Systems and Safety Syringes Industry
11. Tornado Medical Systems And A*STARs Institute Of Microelectronics Partner To Commercialise Nanospectrometers For Optical Coherence Tomography Applications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2017)... -- Agragen, LLC, a Cincinnati -based ... and aquacultural feed sectors, announces a significant step ... AGR131.  This drug is designed to trap and ... patients suffering from inflammatory conditions such as rheumatoid ... Biological pharmaceuticals currently used ...
(Date:8/2/2017)...   Marshall County Hospital in Benton, Kentucky has added ... hospital-acquired infections (HAIs). The new addition, Tru-D SmartUVC , short for "total room ultraviolet ... such as C. diff , MRSA, MERS, Ebola and more. ... Tru-D SmartUVC ... Tru-D in action in a patient room ...
(Date:8/1/2017)...   CerSci Therapeutics , a non-opioid drug development ... has received notice from the National Institute on Drug ... that it has been awarded a Direct-to-Phase II Small ... 2017 with an additional $1,000,000 to follow in 2018. ... of their lead non-opioid drug candidate CT-044 to the ...
Breaking Medicine Technology:
(Date:8/18/2017)... ... August 18, 2017 , ... ... services to communities in east Texas, is launching a regional charity effort to ... Founded in 1991, the Pediatric Brain Tumor Foundation (PBTF) has raised nearly $30 ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
(Date:8/18/2017)... ... 2017 , ... Alcovit, a lime-flavored beverage that rids the body of toxins ... product now available through Jet.com. , After 25 years of development, the company ... designed to quickly detox the body thereby avoiding alcohol-induced hangovers. Whether you’re having fun ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Dangerous Inheritance”: a ... author, Diane Winters. Diane is from Southwest Nebraska where she was raised on ... and family. The story is fictional, but the friendships and mantra of ‘neighbors ...
(Date:8/18/2017)... ... August 18, 2017 , ... Rollon Skin ... anti-aging skincare solutions, recently announced the launch of two new skincare products, ... yet effective alternative to expensive plastic surgery or in-patient cosmetic dermatological procedures. , ...
Breaking Medicine News(10 mins):